China’s Biotech Learning Curve

Here’s the latest news from the global pandemic.

For much of this year, the efficacy rate of a Chinese vaccine made by Beijing-based Sinovac Biotech has been the topic of concern as three different sets of data— with protection rates ranging from 50% to 90%—emerged from clinical trials in Brazil, Turkey and Indonesia.